Tag
#glp-1
13 studies
Oral Semaglutide Shows Promise in Reducing Heavy Drinking
A new clinical trial suggests the blockbuster drug semaglutide could help people struggling with alcohol use disorder cut back on heavy drinking.
Read AnalysisPopular Diabetes Drugs Linked to Better Breast Cancer Survival
A massive retrospective study suggests that GLP-1 receptor agonists may dramatically lower mortality and recurrence rates for breast cancer patients with obesity or type 2 diabetes.
Read AnalysisWeight Loss Drugs vs. Dieting: Which Shrinks Muscle More?
A new study reveals that popular weight loss drugs and standard dieting cause similar amounts of muscle loss, but one key habit can protect your lean mass.
Read AnalysisGLP-1 Drug Semaglutide Fails to Slow Early Alzheimer's
A major phase 3 trial reveals that oral semaglutide does not slow cognitive decline in patients with early-stage Alzheimer's disease.
Read AnalysisBeyond Weight Loss: What GLP-1 Drugs Do to Your Body
While GLP-1 medications are famous for treating diabetes, a massive new study reveals how they impact everything from your gut to your lungs.
Read AnalysisNew Daily Pill Outperforms Semaglutide for Blood Sugar Control
A new once-daily oral drug called orforglipron may lower blood sugar levels more effectively than oral semaglutide.
Read AnalysisSemaglutide Significantly Reduces Heavy Drinking in Clinical Trial
A landmark clinical trial reveals that the popular drug semaglutide can dramatically curb heavy drinking days in patients with alcohol use disorder.
Read AnalysisWhat Happens After You Stop Semaglutide or Tirzepatide?
A new study reveals what actually happens to patients' weight a year after discontinuing popular GLP-1 medications.
Read AnalysisNew Daily Pill Shows Promise for Diabetes and Weight
A new phase 3 trial reveals that a daily oral pill called orforglipron could provide a highly effective, injection-free alternative for managing type 2 diabetes and body weight.
Read AnalysisWomen Lose More Weight Than Men on GLP-1 Medications
A new analysis reveals that popular GLP-1 medications lead to significantly more percentage body mass reduction in women than in men.
Read AnalysisSemaglutide May Outperform Tirzepatide for Heart Health in Obesity
A new real-world study suggests semaglutide provides greater protection against major cardiovascular events than tirzepatide in overweight adults with prior heart disease.
Read AnalysisProtecting Your Muscle While Taking GLP-1 Weight Loss Drugs
While GLP-1 weight loss medications offer incredible benefits, a new review highlights the critical need to protect against accompanying muscle loss.
Read AnalysisTirzepatide Outperforms Semaglutide in Real-World Six-Month Comparison
A real-world comparison reveals that tirzepatide drives significantly greater results than semaglutide over six months.
Read Analysis